Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Term Follow-Up of CARTISTEM vs Microfracture for Knee Cartilage Defects
NCT01626677Phase 3Completed
- Sponsor
- MEDIPOST
- Start
- Jun 2012
- Primary completion
- May 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Cartistem in osteoarthritis (OA), Articular cartilage defect, sponsored by MEDIPOST. Started Jun 2012; status: completed.
02
Drugs
Cartistem
03
Conditions
osteoarthritis (OA)Articular cartilage defect
Beyond the preview
Go deeper on NCT01626677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01626677.